PAIOF (Paion AG) EV-to-EBIT: -0.01 (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PAIOF Paion AG PAIOF
10 GF Score
Price $0.07
View Full Analysis

What is Paion AG EV-to-EBIT?

Paion AG PAIOF 10 EV-to-EBIT is -0.01 as of Jul. 19, 2026. GuruFocus rates PAIOF with a GF Score™ of 10/100.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Paion AG's Enterprise Value is $0.11 Mil. Paion AG's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was $-17.65 Mil. Therefore, Paion AG's EV-to-EBIT for today is -0.01.

The historical rank and industry rank for Paion AG's EV-to-EBIT or its related term are showing as below:

PAIOF's EV-to-EBIT is not ranked *
in the Drug Manufacturers industry.
Industry Median: 15.8
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Paion AG's Enterprise Value for the quarter that ended in Jun. 2023 was $24.69 Mil. Paion AG's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was $-17.65 Mil. Paion AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -71.46%.

Paion AG  (OTCPK:PAIOF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Paion AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2023 ) =EBIT / Enterprise Value (Q: Jun. 2023 )
=-17.647/24.69396
=-71.46 %

Paion AG's Enterprise Value for the quarter that ended in Jun. 2023 was $24.69 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Paion AG's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was $-17.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Paion AG EV-to-EBIT Related Terms

Paion AG EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Paion AG's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Paion AG EV-to-EBIT Chart

Paion AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.42 -12.45 88.69 -4.89 15.53

Paion AG Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22.93 -4.89 -19.43 15.53 -15.54

PAIOF vs ZTS, NBIX, VTRS: EV-to-EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Paion AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Paion AG EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Paion AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Paion AG's EV-to-EBIT falls into.


PAIOF
10GF Score
Paion AG PAIOF
EV-to-EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Paion AG EV-to-EBIT Calculation

Paion AG's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.110/-17.647
=-0.01

Paion AG's current Enterprise Value is $0.11 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Paion AG's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was $-17.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBIT →
What does a EV-to-EBIT of -0.01 mean?
Paion AG (PAIOF) has a EV-to-EBIT of -0.01 as of Jul. 19, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Paion AG and its competitors.
Is Paion AG's EV-to-EBIT too high?
Paion AG's current EV-to-EBIT is -0.01. Overall, Paion AG has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Paion AG's EV-to-EBIT compare to ZTS and NBIX?
Paion AG's EV-to-EBIT of -0.01 can be compared against companies in the Drug Manufacturers industry. The industry median EV-to-EBIT is 15.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Drug Manufacturers company?
The median EV-to-EBIT among Drug Manufacturers companies is 15.80, based on 689 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Paion AG and its competitors. For the Drug Manufacturers industry, the median EV-to-EBIT is 15.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paion AG's current EV-to-EBIT is -0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paion AG stock overvalued right now?
Paion AG (PAIOF) has a current EV-to-EBIT of -0.01. The current EV-to-EBIT is -0.01. Paion AG's overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Paion AG (PAIOF), the current EV-to-EBIT is -0.01 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Paion AG Business Description

Address Heussstrasse 25, Aachen, DEU, 52078
Paion AG is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for procedural sedation, anesthesia, and critical care services. The key product of the company is remimazolam, which is an ultra-short-acting intravenous benzodiazepine sedative. In the human body, remimazolam is rapidly metabolized to an inactive metabolite by tissue esterases and not metabolized by cytochrome-dependent hepatic pathways. The organization is based in Germany.
10GF Score

Get the complete analysis for PAIOF

EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.07
Price